Rentokil Terminix Celebrates Merger With $200,000 Donation to St. Jude Children’s Research Hospital
28 Oktober 2022 - 2:00PM
Business Wire
Rentokil Terminix, North America’s largest pest control company,
today announced a recent donation of $200,000 to St. Jude
Children’s Research Hospital®. The donation commemorates the merger
of two leading pest control companies, Rentokil and Terminix, to
form Rentokil Terminix in North America.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20221018006104/en/
Rentokil Terminix, North America’s
largest pest control company, today announced a recent donation of
$200,000 to St. Jude Children’s Research Hospital®. The donation
commemorates the merger of two leading pest control companies to
form Rentokil Terminix in North America. Pictured (L-R) are Brett
Ponton, CEO of Rentokil Terminix, Andy Ransom, CEO of parent
company Rentokil Initial plc., John Myers, CEO of U.S. Pest Control
for Rentokil North America, and Richard C. Shadyac Jr., president
and CEO of ALSAC, the fundraising and awareness organization for
St. Jude. (Photo: Business Wire)
The check presentation event, which took place at the Terminix
headquarters in Memphis, Tenn., was led by executive leaders Andy
Ransom, CEO of parent company, Rentokil Initial plc., Brett Ponton,
CEO of Rentokil Terminix, North America, and John Myers, CEO of
U.S. Pest Control. Richard C. Shadyac Jr., president and CEO of
ALSAC, the fundraising and awareness organization for St. Jude
Children's Research Hospital, was present to accept the donation
for St. Jude.
“We are so thankful for the support of Rentokil Terminix in the
lifesaving mission of St. Jude Children’s Research Hospital,” said
Shadyac. “This donation will help fuel St. Jude’s ongoing $12.9
billion strategic plan that grows investment in global childhood
cancer research and care, all from right here in the great city we
both call home.”
“We are delighted to make this donation to the children and
families of St. Jude on behalf of our colleagues around North
America,” said Brett Ponton. “This donation is just another example
of why our newly combined company makes so much sense. Each of our
organizations were, and are now, even more committed to giving back
to the communities where we live and work.”
St. Jude Children’s Research Hospital accepts children from all
50 states and around the world. Thanks to generous donors, families
never receive a bill from St. Jude for treatment, travel, housing,
or food so they can focus on helping their child live. The mission
of St. Jude Children’s Research Hospital is to advance cures and
means of prevention for pediatric catastrophic diseases through
research and treatment. The donation will support the world-class
research and groundbreaking care taking place every day at St.
Jude.
“I can’t think of a better way to kick off our exciting future
than celebrating this core value we all share,” continued Ponton.
“We look forward to many more years of partnership with St. Jude
and serving this cause.”
For more information about the newly combined company, Rentokil
Terminix, please visit EnhancedPestControl.com.
About RENTOKIL TERMINIX
For more than 90 years, Rentokil and Terminix have been
protecting people and enhancing lives. In North America, Rentokil
Terminix consists of several trusted residential and commercial
pest control companies - including Rentokil, Terminix, Ehrlich,
Florida Pest Control, Presto-X and Western Exterminator.
Additionally, Rentokil North America operates business services
companies including Ambius, specializing interior landscaping and
scenting; Steritech, offering food safety and operational
assessments; SOLitude Lake Management, providing lake and pond
solutions; and Vector Disease Control International, which serves
governments and municipalities with mosquito control services.
About St. Jude Children’s Research Hospital®
St. Jude Children’s Research Hospital is leading the way the
world understands, treats and defeats childhood cancer and other
life-threatening diseases. Its purpose is clear: Finding cures.
Saving children.® It is the only National Cancer
Institute-designated Comprehensive Cancer Center devoted solely to
children. Treatments invented at St. Jude have helped push the
overall childhood cancer survival rate from 20% to more than 80%
since the hospital opened in 1962. St. Jude won’t stop until no
child dies from cancer. St. Jude shares the breakthroughs it makes,
and every child saved at St. Jude means doctors and scientists
worldwide can use that knowledge to save thousands more children.
Because of generous donors, families never receive a bill from St.
Jude for treatment, travel, housing or food, so they can focus on
helping their child live. Visit St. Jude Inspire to discover
powerful St. Jude stories of hope, strength, love and kindness.
Join the St. Jude mission by visiting stjude.org, liking St. Jude
on Facebook, following St. Jude on Twitter, Instagram, LinkedIn and
TikTok, and subscribing to its YouTube channel.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221018006104/en/
MEDIA CONTACT: Hannah Bernhard
Hannah.Bernhard@rentokil.com
Rentokil Initial (NYSE:RTO)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Rentokil Initial (NYSE:RTO)
Historical Stock Chart
Von Nov 2023 bis Nov 2024